Ocular Therapeutix Inc (OCUL) financials · rev $52.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Ocular Therapeutix Inc (OCUL) rev $52.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $52.0M | $63.7M |
| Cost of Revenue | $6.57M | $5.63M |
| Gross Profit | $45.4M | $58.1M |
| Operating Income | -$270.0M | -$171.8M |
| Net Income | -$265.9M | -$193.5M |
| EPS (Diluted) | -$1.42 | -$1.22 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $808.1M | $457.9M |
| Current Assets | $782.1M | $441.0M |
| Cash & Equivalents | $737.1M | $392.1M |
| Inventory | $3.56M | $3.04M |
| PP&E | $19.7M | $9.39M |
| Total Liabilities | $153.7M | $142.6M |
| Current Liabilities | $50.8M | $41.4M |
| Shareholders' Equity | $654.3M | $315.3M |
| Retained Earnings | -$1.16B | -$891.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$204.9M | -$134.7M |
| CapEx | $12.0M | $1.29M |
| Investing Cash Flow | -$11.9M | -$1.29M |
| Financing Cash Flow | $561.7M | $332.1M |
| Net Change in Cash | $345.0M | $196.1M |
| Free Cash Flow | -$216.9M | -$136.0M |
FAQ
What is OCUL P/E and revenue?
Ocular Therapeutix Inc (OCUL) rev $52.0M.
What is OCUL revenue?
Ocular Therapeutix Inc last cached revenue is $52.0M (FY2025).
Is OCUL profitable?
Ocular Therapeutix Inc last cached net income is -$265.9M (FY2025).
What are OCUL total assets?
Ocular Therapeutix Inc last cached total assets are $808.1M (FY2025).
What is OCUL free cash flow?
Ocular Therapeutix Inc last cached free cash flow is -$216.9M (FY2025).
Not investment advice. Cached statements, not a live tape.